about
Mild form of 2009 H1N1 influenza infection detected by active surveillance: implications for infection control.A prediction rule to identify severe cases among adult patients hospitalized with pandemic influenza A (H1N1) 2009.Can a routine follow-up blood culture be justified in Klebsiella pneumoniae bacteremia? A retrospective case-control studyRapid identification of the coxsackievirus A24 variant by molecular serotyping in an outbreak of acute hemorrhagic conjunctivitis.Incidence of atazanavir-associated hyperbilirubinemia in Korean HIV patients: 30 months follow-up results in a population with low UDP-glucuronosyltransferase1A1*28 allele frequency.Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infectionPseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae.Inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureusSeverity predictors in eschar-positive scrub typhus and role of serum osteopontin.Urbanization of scrub typhus disease in South Korea.Why is asymptomatic bacteriuria overtreated?: A tertiary care institutional survey of resident physicians.Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposureEmpirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high.Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak.Serotype Distribution and Antimicrobial Susceptibilities of Invasive Streptococcus pneumoniae Isolates from Adults in Korea from 1997 to 2012In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey.Immunologic diagnosis of active tuberculosis.Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection.High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy.Low compliance with national guidelines for preventing transmission of group 1 nationally notifiable infectious diseases in Korea.Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea.A comparative study of pyogenic and tuberculous spondylodiscitis.Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.Vertebral osteomyelitis caused by non-tuberculous mycobacteria: Predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature.Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection.Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study.Discrepancy in perceptions regarding patient participation in hand hygiene between patients and health care workers.An outbreak of Burkholderia cepacia complex pseudobacteremia associated with intrinsically contaminated commercial 0.5% chlorhexidine solution.Diagnostic value of direct fluorescence antibody staining for detecting Pneumocystis jirovecii in expectorated sputum from patients with HIV infection.Predictors of Treatment Success for Multidrug Resistant Tuberculosis.Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1*28 allele frequency.A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea.Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media.Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.Determination of genetic subtypes of HIV type 1 isolated from Korean AIDS patients.Late presentation of HIV disease and its associated factors among newly diagnosed patients before and after abolition of a government policy of mass mandatory screening.Usefulness of routine lumbar puncture in non-HIV patients with latent syphilis of unknown duration.
P50
Q30388505-66B80127-FD08-4AAF-BAAA-F51D39EA9A41Q30401555-E1E92A22-2D32-4F28-8919-7417E867EAA9Q31125767-6D91C0A0-D05A-4D48-8873-DF5AD294A24BQ33752820-4A994F58-391D-4625-8C88-B0C86CB5B483Q34159702-BEDFD8DD-EE86-40B1-B525-1164EF507840Q34649281-8125172C-B796-4A81-9166-0F122A40A1D9Q34839432-F1E6F755-3BA9-4A3E-B3EB-E10D9E7109BBQ35105928-6F5637E4-61CC-4FCF-AD59-7AF5193FAA8EQ35494593-05CE7FA3-6DE9-4321-B812-C5926B9D8D3BQ35636973-5CF50372-4444-4B0D-A68B-A45DA11022ACQ35713467-06E2F534-44ED-4848-8197-276E75A5E245Q35867351-460DC8F9-1E9A-4103-B81A-65255962A0DFQ36018630-492AD7A9-5D24-4EDD-B32B-2E71E016046EQ36353976-22EF832D-F0F7-43D3-B8D9-08C87B1234CDQ36510031-05C56124-BC4B-4E84-B40C-C72FCE8A41CEQ36809649-0DE7DEF4-4355-42D2-9B85-18E2B0FA1047Q37118969-7F3719AA-D8F5-4FF1-A14B-51BA87300C0BQ37192130-24E9E8DF-7A01-4A53-8226-0A9A300B73D9Q37323397-227FE394-6E35-41CD-AD41-DA6D85F45BCEQ37466644-1AF64AF6-2022-40B3-84FA-28B3780232D2Q37606722-CBFD6708-2720-45B8-9FED-62C50184733DQ37740446-5F702C8C-E901-41FE-B987-3DB593B173D1Q37788517-2F6F8E5F-AF60-4179-AE22-FC0399C37CB1Q38479164-AEC20C75-8CCA-472F-987C-1B2AFB1CB89CQ38784500-19D6695F-7FA6-4E67-9F21-B67BC429DEA7Q40065997-41DFEFCE-E385-46C3-A196-BF4CF30CAC80Q40922287-A5936B3A-7287-4474-B026-51615112A736Q41094417-8E8C3C44-C5EA-40B6-9F8E-77778784E168Q41442092-89ABC898-CA3A-4B47-ABFD-8F2EEA38AED5Q41564357-14D5C569-837B-4E08-8E3D-096A592BD043Q42229132-1F6CB72F-8620-496B-BCB6-2D65F061FE17Q42335957-A13BAD0F-C262-4E27-9647-6BB5DAD8A248Q43053805-9706D726-A9CA-461D-8652-46C8AD0296D3Q44258062-AB6F4CF1-7808-4516-8406-1705F672A6D3Q45938231-DC95174B-3CFE-4FAA-896E-9C1149BE3F14Q47646856-7971CA4C-FCA5-4B55-B65B-F5E31FEE3E09Q48214491-8D48968F-421C-4361-8DF7-2BA90CF9EADEQ48268453-965F72A1-BDF3-4F15-8FC1-950245E16942Q50105797-A3E4924C-66D8-480D-8A2B-4C3AFC1F073CQ51804234-165FEDCE-5473-4DA1-923F-05405B80F55C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sang Won Park
@ast
Sang Won Park
@en
Sang Won Park
@es
Sang Won Park
@nl
type
label
Sang Won Park
@ast
Sang Won Park
@en
Sang Won Park
@es
Sang Won Park
@nl
prefLabel
Sang Won Park
@ast
Sang Won Park
@en
Sang Won Park
@es
Sang Won Park
@nl
P106
P1153
56108350600
P31
P496
0000-0002-0550-1897